FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:1603-1605 April 14, 2005 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Ridker, P. M PubMed Citation

To the Editor: Ridker and colleagues (Jan. 6 issue)¹ suggest that statin therapy be targeted to achieve a C-reactive protein (CRP) level of less than 2.0 mg per liter in patients with a recent acute coronary syndrome. Having examined the data presented in Table 1 of the article, we question this conclusion. After adjustment for known cardiac risk factors, the relative risk of recurrent coronary events was appreciably increased only in patients whose CRP level was in the highest quartile (>4.2 mg per liter). Patients whose CRP level was in the second or third quartile (0.9 to 4.2 mg per . . . [Full Text of this Article]

This article has been cited by other articles:

• Ray, K. K., Cannon, C. P., Cairns, R., Morrow, D. A., Rifai, N., Kirtane, A. J., McCabe, C. H., Skene, A. M., Gibson, C. M., Ridker, P. M., Braunwald, E., for the PROVE IT-TIMI 22 Investigators, (2005). Relationship Between Uncontrolled Risk Factors and C-Reactive Protein Levels in Patients Receiving Standard or Intensive Statin Therapy for Acute Coronary Syndromes in the PROVE IT-TIMI 22 Trial. J Am Coll Cardiol 46: 1417-1424 [Abstract] [Full Text]  
• Ray, K. K., Cannon, C. P. (2005). The Potential Relevance of the Multiple Lipid-Independent (Pleiotropic) Effects of Statins in the Management of Acute Coronary Syndromes. J Am Coll Cardiol 46: 1425-1433 [Abstract] [Full Text]